Ampersand makes offer for AcCell product line:
This article was originally published in Clinica
Executive Summary
Ampersand Medical has offered to buy AccuMed International's AcCell product line, including intellectual property and AccuMed's contracted customer base, for cash, royalties and a licence back for certain AccuMed technology. The AcCell system is a range of automated computer-assisted microscopy work-stations and software that are integrated with lab information systems for the screening and diagnosis of cervical Pap smears and cytology specimens. Chicago-based Ampersand wishes to integrate aspects of the system into its bio-molecular diagnostic systems.